Fracture risk in trans women and trans men using long-term gender-affirming hormonal treatment: A nationwide cohort study
Journal of Bone and Mineral Research Sep 12, 2019
Wiepjes CM, de Blok CJM, Staphorsius AS, et al. - Researchers contrasted the fracture incidence in transgender people using long-term hormonal treatment (HT) with an age-matched reference population. For this nationwide cohort study, all adult transgender people at the gender identity clinic who began HT before 2016 were involved and connected to a random population-based sample of 5 age-matched reference males and 5 age-matched reference females per individual. The study sample consisted of 1,089 trans women < 50 years (mean 38 ± 9) and 934 trans women ≥ 50 years (mean 60 ± 8) using HT for median 8 (IQR 3-16) and 19 (IQR 11-29) years, respectively. Compared with age-matched reference men, fracture risk was higher in older trans women. Fracture risk tended to be increased vs age-matched reference women in young trans women. In young trans men, the risk of fracture was not increased.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries